InvestorsHub Logo
Followers 137
Posts 22811
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Friday, 08/29/2014 10:03:26 AM

Friday, August 29, 2014 10:03:26 AM

Post# of 2205
Think about this

Earlier this year Calimmune was having difficulty screen for the last patient in their first dose cohort, because they were screening one patient at a time and if a patient failed the screening they would have to start screening another patient from the beginning. The screening took a month or more. They changed their screening procedure to allow them to screen up to 4 patients at a time. Now Calimmune's trial and dosing schedule is back on track and on schedule.

Does that sound familiar? To quote Yogi Berra "It's déjà vu all over again".

Now Benitec's trial to cure hepatitis C has a schedule that is back on track and on schedule.

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News